Hypertension is the most prevalent comorbidity (38%) in patients with cancer and is considered an important modifiable risk factor for the development of cardiovascular events, including heart failure (HF). Importantly, hypertension may worsen the prognosis of patients with cancer and the severity of some types of cancer., In addition, cancer treatments may aggravate pre-existing or even cause new hypertension,, making the role of this risk factor even more complex and multifaceted. It is important to note that the use of […]